As The MedTech CRO, we’re much more than a MedTech consulting company; we’re your strategic partner in mutual success. Our experienced team uncovers the unknowns, guiding you through the nuances of regulatory compliance and market access. We’re your single stop for consulting services, lab expertise, clinical trial management and execution, and reimbursement solutions to provide full lifecycle support for your MedTech products.
With expertise in medical devices, diagnostics, and combination products, plus leading-edge technology and a people-centric approach, we ensure your innovations reach patients — faster, safer, better.
Our MedTech Consulting Solutions
Our portfolio of MedTech consulting solutions and services spans the entire product lifecycle to accelerate your success:
Our Core Priorities
-
Customer Service
We’re passionate about client success and laser-focused on delivering transformative solutions that meet your unique needs.
-
Client Collaboration
We take a tailored, business-balanced approach to every project, delivering right-sized solutions that align with your program’s goals.
-
Building Trust
Our goal is to be the world’s most trusted and valued partner to medical device and diagnostics manufacturers.
-
Thought Leadership
We strengthen the MedTech industry through expert insights, industry collaborations, and active participation in regulatory and standards development.
-
Evolving Expertise
We invest in ongoing education and knowledge sharing to stay ahead of industry changes.
-
Employee Satisfaction
We cultivate a culture of empathy, integrity, and pride, creating an environment where our people thrive.
The Evolution of RQM+
2008
- R&Q solutions founded
- Focused on RA/QA MedTech consulting in the U.S.
2020
- Acquired Maetrics (est. 1984), renamed company RQM+
- Doubled company size, expanding RA/QA consulting services
2021
- Linden acquires RQM+
- Launch of value creation plan to expand services
- Acquired AcKnowledge Regulatory Strategies (est. 2014)
2022
- Added industry-leading lab services recognized by the FDA through acquisition of Jordi Labs (est. 1980)
- Expanded clinical trials & reimbursement services
2023
- Acquired Libra Medical (est. 2007) and CRO Kottmann (est. 2008)
- Strengthened clinical trial services with first-in-human studies expertise and tripling team
- Expanded European clinical trial capabilities
- Brought 25+ years of MedTech leadership